← Open Payments lookup

LESLIE STELLY: Open Payments

NPI 1205448651 · WELSH, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$507 in 24 payments from 10 companies in 2025. Trend: 2023 $440 · 2024 $270 · 2025 $507

Food & beverage: $507
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$160
Lilly USA, LLC6$118
Axsome Therapeutics, Inc.4$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$51
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Takeda Pharmaceuticals U.S.A., Inc.1$17
Supernus Pharmaceuticals, Inc.1$16
ABBVIE INC.1$16
Vanda Pharmaceuticals Inc.1$15
Bayer Healthcare Pharmaceuticals Inc.1$14

Products named: JARDIANCE, FARXIGA, Auvelity, CAPLYTA, BREZTRI, TRINTELLIX, Qelbree, VRAYLAR.

Industry payments across LA — which companies pay providers there.